Iris Interactive: Drug Development with Speed, Efficiency and Quality

"Knowledge gathered in drug development does not get shared adequately," according to Janaki Joshi, Chief Executive Officer, Iris Interactive Corporation. "Every week of delay costs millions of dollars. There is a need for a centralized platform to manage information, so all teams can operate more efficiently, benchmark, monitor how long processes take, identify sources of delay and quickly fix them," she suggests.read more